Clinical Trial

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will be conducted to determine the clinical efficacy of axatilimab in Japanese participants with chronic graft-versus-host disease (cGVHD).
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2024-02-09; most recent amendment 2026-01-06.
Status change: Recruiting → Active, Not Recruiting 2025-02-04
Status change: Not Yet Recruiting → Recruiting 2024-06-21
Trial Details
NCT Number NCT06263478
Lead Sponsor Incyte Biosciences Japan GK
Conditions Chronic Graft-versus-host-disease
Enrollment 21 participants
Start Date 2024-07-30
Primary Completion 2025-08-06 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-07